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Abstract Animal models have contributed to our under-
standing of breast cancer, with publication of results in
high-impact journals almost invariably requiring extensive
in vivo experimentation. As such, many laboratories hold
large collections of surplus animal material, with only a
fraction being used in publications relating to the original
projects. Despite being developed at considerable cost, this
material is an invisible and hence an underutilised
resource, which often ends up being discarded. Within the
breast cancer research community there is both a need and
desire to make this valuable material available for
researchers. Lack of a coordinated system for visualisation
and localisation of this has prevented progress. To fulfil
this unmet need, we have developed a novel initiative
called Sharing Experimental Animal Resources: Coordi-
nating Holdings—Breast (SEARCHBreast) which facili-
tates sharing of archival tissue between researchers on a
collaborative basis and, de facto will reduce overall usage
of animal models in breast cancer research. A secure
searchable database has been developed where researchers
can find, share, or upload materials related to animal
models of breast cancer, including genetic and transplant
models. SEARCHBreast is a virtual compendium where
the physical material remains with the original laboratory.
A bioanalysis pipeline is being developed for the analysis
of transcriptomics data associated with mouse models,
allowing comparative study with human and cell line data.
Additionally, SEARCHBreast is committed to promoting
the use of humanised breast tissue models as replacement
alternatives to animals. Access to this unique resource is
freely available to all academic researchers following
registration at https://searchbreast.org.
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Introduction
Pre-clinical studies in animals have translated to human
benefit in breast cancer. A key example is the pharma-
ceutical tamoxifen, which has saved the lives of millions of
people diagnosed with oestrogen receptor positive (ER?)
breast cancer. Its approval as a clinical therapy was aided
by elegant work with rodents conducted in the 1970s [1, 2].
This work also demonstrated the benefits of tamoxifen in
breast cancer chemoprevention [3, 4]. Other examples
resulting from initial pre-clinical studies in rodents include
work leading to the development of trastuzumab [5, 6], and
aromatase inhibitors [7, 8] as targeted therapies in clinical
breast cancer. Results generated using in vitro models do
not translate directly into clinical trials hence a stage of
animal experimentation is involved in the development of
novel breast cancer therapies. In addition, publication of
studies in high-impact journals most often requires that
data are verified in at least one (and sometimes in several)
in vivo model. As an example, [9] used the MMTV-v-Ha-
ras transgenic mouse model, developed originally by the
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Leder [10] and Jolicoeur groups [11] to examine the
potential role of farnesyltransferase inhibitors on tumour
regression. Similarly, the efficacy of dipyridamole in pre-
venting breast cancer initiation, progression and metastasis
was tested in MMTV-PyMT transgenic mice [12], which
were developed originally by the Muller lab [13]. Of these
two examples (there are many more, as reviewed by [14])
both required extensive breeding programmes and subse-
quent hypothesis testing. Hence, a single project may
involve the use of a large number of animals, each gen-
erating surplus tissues and other material that potentially
could be utilised in future studies by other research groups.
Animal research includes syngeneic, xenograft and
genetically modified (GEM) models. These are now an
integral part of thousands of original publications each year,
yielding significant advances across many research fields.
However, this results in significant animal sacrifice; in 2013
alone, an estimated 20 million animals were used in scien-
tific studies in the European Union and the United States.
Scientists are encouraged to consider alternatives before
embarking on new animal experiments, including due dili-
gence on the validity of the model being considered in
recapitulating human disease and/or phenotype, as well as
employing the principles of the 3Rs—Replacement,
Reduction and Refinement. The 3Rs were developed over
50 years ago as a framework for humane animal research
[15] and is now part of national and international legislation
regulating the use of animals in experiments. Not generally
considered in this context is the potential wastage of surplus
material from animal studies, or whether material is already
available that can be used to answer the research question.
Typically, research groups tend to collect materials from
their projects, with the surplus sometimes being stored
indefinitely, but also frequently being discarded at the end of
the project. While the collection, storage, archiving and
access policies for human clinical samples and transcrip-
tomic data are routinely included in grant applications and
often manuscript submissions, there is no obligation for
investigators using animal models to do the same. This has
economic, scientific and ethical shortcomings, resulting in
considerable waste including duplication of experiments.
This potentially lost material represents a valuable resource
that could be used productively if there was a way for other
researchers to identify it. Furthermore, if pre-existing
models or materials were accessible elsewhere, obtaining
these instead of recreating themwould lead to fewer animals
being used, as well as saving both time and money [16],
illustrated schematically in Fig. 1. Currently, researchers
lack the resources (money, databases, space, time) to gen-
erate and maintain systems that would catalogue their
archival material and make it visible to other interested
parties. SEARCHBreast therefore provides the missing link
between those who have material available and those who
would like to access existing samples, rather than repeating
studies that have already been done. In particular, investi-
gators without access to animal facilities may benefit from
joining SEARCHBreast, providing them with an opportu-
nity to carry out the type of studies that would increase the
impact of their research.
Establishing SEARCHBreast for more efficient use
of materials derived from breast cancer studies
in animals
Recognising that the majority of available animal resources
physically store and provide live animals (e.g. The Jackson
Laboratory, [17] or The Knockout Mouse Project (KOMP)
Repository [18] which uses embryonic stem cells to create
new genetic models), we considered that a virtual resource
which made pre-existing archived materials already gen-
erated from animal models, more visible and accessible to
the breast cancer research community, would be attractive
to researchers. This would provide scientists with the
opportunity of fostering greater collaborations, while at the
same time reducing the numbers of animals used and
encouraging better use of animal models. To confirm the
need for such a resource, a widespread consultation was
conducted with the UK breast cancer research community,
resulting in overwhelming support for the initiative. As a
result, Sharing Experimental Animal Resources: Coordi-
nating Holdings—Breast (SEARCHBreast) was created,
with funding secured through an Infrastructure for Inno-
vation award from the National Centre for the Replace-
ment, Refinement & Reduction of Animals in Research
(NC3Rs). The resource provides scientists with the
opportunity for surplus animal tissue to be utilised by other
breast cancer investigators to further their studies, after the
initial holder of the materials has finished their work. Thus,
scientists requiring animal models or derived materials are
provided with a mechanism for finding and accessing those
generated by expert groups, avoiding the need to create
in vivo models from scratch and/or validating a pathway of
interest in accurate models prior to embarking on time
consuming and expensive breeding regimes. Through this,
SEARCHBreast aims to address each of the Replacement,
Reduction and Refinement aspects of the 3Rs, while also
accelerating breast cancer research.
SEARCHBreast: a comprehensive database
of breast cancer mouse models
SEARCHBreast does not physically store material; the
database is a virtual online resource available through the
website, https://searchbreast.org. The database consists of
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descriptions of animal models (syngeneic, xenograft (in-
cluding PDX) and GEM) and associated tissue and mate-
rials (mainly FFPE tissues and histological slides), which
are available for sharing between academics within the
breast cancer research community on a collaborative basis.
The SEARCHBreast visual identity and strapline; con-
nect, share, discover (Fig. 2) embraces our ethos of con-
necting breast cancer researchers to encourage sharing of
resources, knowledge and ideas thereby increasing the
quality of research outputs to discover more about breast
cancer. We developed the resource by inviting key UK
breast cancer researchers with a track record in the use of
complex model systems to attend two initial workshops.
Their input helped shape the structure and content of the
SEARCHBreast database. This was an iterative process to
develop a system that contained sufficient information to
facilitate the localisation of the material that was quick and
easy to use for scientists. The database contains key
information about the material available (e.g. tumour type,
metastasis, fixation method), and additional details (e.g.
therapeutic doses, time points, group sizes, analyses
already performed) are exchanged once a collaboration is
agreed. This approach aims to make the material entry
process as simple as possible, minimising the time it takes
to register material. The types of information captured and
the materials available are shown in Table 1.
The website and underlying database are designed for
security. They have access restrictions and password
encryption, and additional security features have been
incorporated. All users of SEARCHBreast wishing to view
the materials available are first required to register. Once
registered, they can upload models they may have available
to share, or search the database for material that may
augment their research. Having identified material they
wish to use, researchers can request it from the holder, via
an email enquiry to the SEARCHBreast coordinator. The
name of the holder and their institution are not identified
when the database is viewed. If the owner chooses to share,
they contact the requestor and the collaboration proceeds
according to the regulations of the institutions involved
(Fig. 3). Importantly, there is no obligation to share the
material registered in SEARCHBreast. If the holder of the
Research question: Is molecule X expressed in breast tumours?
Establish in vivo models and 
determine expression of X
Use SEARCHBreast to obtain tumour
material  - is X expressed?
1) Write grant application to 
obtain funding for model 
2) Establish model system, 
train staff, obtain licenses
3) Carry out experiments – grow 
tumours, analyse expression
12 months
6 months
6 months
Answer: In 24 months at a cost of  £100K/ 
$142K, dependent on obtaining grant 
funding 
1) Register as member of 
SEARCHBreast
2) Search database, locate 
and obtain material
3) Stain tumours, analyse
expression
< 1 week
4 weeks
4 weeks
Answer: In 2 months at cost of reagents 
only and no grant funding required
(a) (b)
Fig. 1 An example of the benefits of using SEARCHBreast to source
material, to study if molecule X is expressed in breast tumour models.
The cost/time required for generation of material from scratch is
shown in a while in b the same process using SEARCHBreast is much
faster and at minimal cost to the researcher. This has the added
advantage of identifying the most relevant model for future studies
from a more extensive range of models than may be available to the
researcher locally
Fig. 2 SEARCHBreast logo and strapline
Breast Cancer Res Treat (2016) 156:447–452 449
123
material considers that a proposed collaboration is not of
interest/benefit/sufficient quality etc., they are entitled to
decline the invitation to share. The response is communi-
cated by the SEARCHBreast coordinator. No costs are
associated with using SEARCHBreast; registration,
depositing and searching are free of charge. Subsequent
costs for material exchanged is by arrangement between
the collaborating researchers. SEARCHBreast only ask that
they are acknowledged in publications arising from pro-
ductive exchanges.
Resource tools to improve the use of animals
in research
As well as widening access to archival animal materials,
the SEARCHBreast website can be used to assist
researchers apply the 3Rs to their work. Links to online
technical information written by experts provide standard
operating procedures (SOPs) that give guidelines on
experimental procedures for animal models.
Although scientists should consider the 3Rs in their
research, an unintended consequence is the increasing
prevalence of underpowered results that invalidate studies
through few samples being used. This leads to wasted
material through ill-considered experimental design [19].
The SEARCHBreast website provides links to additional
resources to assist researchers in, for example, determining
the correct sample size during the design of their experi-
ments using Experimental Design Assistant [20]
A bioinformatics pipeline is being integrated into the
SEARCHBreast website for the analysis of transcriptomics
data associated with the mouse models within the database.
This will allow users to identify models that are known to
reflect changes in certain genes, such as specific onco-
genes. Users will consequently be able to find models that
work best for the molecular investigations they wish to
pursue. To support this, a comparative large-scale analysis
of gene expression profiles from breast cancer mouse
models, human breast cancer samples and cell lines is
underway, with the results being incorporated into the
search facility of the SEARCHBreast database.
Table 1 Information about the type of material available on the SEARCHBreast portal
Mouse information Tissue availablea Phenotypes Analysis performed
Model name, cell line,
Jax stock number, GEM
allele, transplantation
site, strain, sex
Tumour, lung, mammary fat pad, lymph
node, heart, spleen, liver, long bones,
skull, serum, vertebrae, circulating DNA
embryos, sperm, live animals,
ER/PR/HER2 status,
metastasis sites
metastatic penetrance
CK5/CK8/p63/SMA
status
Tumour volume, general histology,
vascularisation, immune infiltrate,
apoptosis, proliferation, transcriptome
analysis, metastatic assay,
microenvironment analysis
a Many of the tissues available are stored as formalin-fixed paraffin-embedded, frozen, or as histological slides, enabling user-friendly samples to
be sent ready for immediate use by scientists
Fig. 3 Schematic of information flow through the SEARCHBreast
website and database. Researchers enter models into the database via
an interface at the website (a). Complemented by bioinformatics
software, it can be searched by scientists looking for models to further
their research (b). Once material is identified this can be requested via
SEARCHBreast (c). The SEARCHBreast website provides access to
other useful online information plus upcoming workshops and events
(d). The expected outputs from SEARCHBreast are shown (e)
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Other features on the website include explanations of the
principles of the 3Rs and links to associated resources,
including the NC3Rs website [21] and the NC3Rs Arrive
guidelines [22] which have been developed to improve the
reporting of animal research, plus information about
upcoming workshops and events hosted by, or attended by,
the SEARCHBreast team.
Humanised 3D models as alternatives to animal
models
A further aim of SEARCHBreast is to promote the use of
alternative humanised models of breast cancer by aligning
with another resource, the Breast Cancer Now Tissue Bank
(BCNTB) [23, 24]. The BCNTB provides human breast
cancer and normal breast tissue for research, and spe-
cialises in providing primary cell cultures derived from
these cells. SEARCHBreast encourages scientists to con-
sider developing 3D cell culture models as an alternative to
animal models. Researchers who apply for human breast
material from the BCNTB will, via SEARCHbreast, have a
mechanism for matching their in vitro work to the most
relevant in vivo model.
In respect of this aim, SEARCHBreast organised a
workshop dedicated to the replacement of animals in breast
cancer research using 3D models. This was a networking
opportunity which focused on practical considerations on
handling humanised cell and tissue models; providing
solutions to the perceived barriers of access to samples; and
tips on establishing primary cultures with a view to using
these in 3D breast cancer models, and introduced new
technology allowing 3D tissue modelling of breast cancer
using virtual pathology [25]. Many of the lectures from this
event are available to view on the SEARCHBreast website
(https://searchbreast.org/) with the workshop proceedings
recently published [26].
Discussion
For breast cancer researchers to publish their work in
higher tier scientific journals it is becoming increasingly
necessary to include an in vivo component, placing pres-
sure on scientists to include animal experimentation.
However, many researchers do not have the expertise or the
financial resources to carry out complex in vivo studies.
SEARCHBreast has begun to address this by making
materials that might otherwise go to waste more visible and
accessible to researchers, potentially increasing the quality
and impact of their research through translation/validation
in an in vivo model. This may benefit early career
researchers in particular, who may require pilot data from
in vivo studies in order to obtain independent funding, as
well as scientists without access to animal facilities or the
necessary legislative approval which in itself can take
months to put in place in some countries. In contrast to the
emphasis put on safe storage, cataloguing, sample tracking
and shared utilisation through tissue access committees for
material generated from human studies, there has been
little interest in developing similar best practise for animal
studies, despite the considerable investment they represent
both in terms of time and money. It is unlikely to remain
acceptable that this potentially valuable resource is dis-
carded due to lack of storage facilities, and funding bodies
may in the future request a plan for storage and sharing of
any excess material. Joining SEARCHBreast represents an
easy and accessible way by which researchers can address
this, as well as increasing the impact of their work.
We anticipate that SEARCHBreast will encourage
funding bodies to include consideration of what to do with
any surplus material at the end of a funded study, and to
stimulate researchers to become members of SEARCH-
Breast and register their available material. Prior to the
establishment of SEARCHBreast, no significant organised
system had been made to enhance visibility and facilitate
sharing of material from animal models of breast cancer.
This pioneering approach aims to produce more efficient
and effective use of these models, opening up new
opportunities in breast cancer research. Importantly, both
parties will benefit from collaborating through sharing
material; the researcher seeking material potentially
avoiding having to do in vivo studies, and the holder of the
material gaining new and unplanned collaborative studies,
through making the otherwise unused resource available.
SEARCHBreast is the initiator and driver of this novel way
of viewing unused material as an untapped enabler of new
research, at the same time firmly addressing the 3Rs.
Furthermore, in the future, this platform may be extended
beyond breast cancer to apply these principles in other
diseases.
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